Citations

Clear

861 citation(s) found for "Sd, Wexner".

Does Diversity of Authorship Matter? An Analysis of Plastic Surgery’s Top 100 Articles
Asserson, Derek B., Janis, Jeffrey E., Janis, Jeffrey E. , Asserson, Derek B.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | March 24, 2022 | Volume: 10 | Issue: 3 | Pages: e4214

10.1097/gox.0000000000004214 | PMID 35356043 Get It

Background: Diversity, whether related to age, gender, ethnicity, race, geography, or experience, is increasing in all realms of medicine, including plastic surgery. Research has also become more diverse in those who conduct studies and those who participate in them. Fittingly, surgeons who produce prominent research are likely to come from diverse backgrounds. This study was designed to analyze the diversity of authorship in peer-reviewed plastic surgery journals. Methods: Using the Web of Science database, the authors identified the 100 most-cited articles from the highest-impact plastic surgery journals from January 2010 to December 2020. Author, institutional, and topic information was collected. Results: There was an average of 5.6 authors on the top 100 articles, of which 96.1% involved collaboration and 75.7% mixed-gender authorship. The average number of affiliations was 2.1, of which 51.5% involved cross-institutional collaboration, 12.6% came from both domestic and international institutions, 30.1% involved multiple specialties, and 10.7% came from both academia and private practice. Having both domestic and international authors was found to be most predictive of more citations on multiple regression, with year as a nonconfounding variable (P < 0.05), followed by mixed-gender authorship (P < 0.10). Conclusion: Impactful publications in plastic surgery come from diverse sets of authors and institutions.
Collaboration and Shared Decision-Making Between Patients and Clinicians in Preventive Health Care Decisions and US Preventive Services Task Force Recommendations
Force, US Preventive Services Task, Davidson, Karina W. , Mangione, Carol M. , Nicholson, Wanda K. , Cabana, Michael D. , Caughey, Aaron B. , Davis, Esa M. , Donahue, Katrina E , Kubik, Martha , Li, Li , Ogedegbe, Gbenga, Silverstein, Michael, Stevermer, James , Tseng, Chien‐Wen , Wong, John B. , Doubeni, Chyke A. , Davidson, Karina , Force, US Preventive Services Task, Barry, Michael J. , Pbert, Lori A.

Mayo Clinic

JAMA | March 22, 2022 | Volume: 327 | Issue: 12 | Pages: 1171

10.1001/jama.2022.3267 | PMID 35315879 Get It

Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient‐level data from 4 prospective trials
Perlow, Haley K. , Prasad, Rahul N. , Yang, Mike, Klamer, Brett , Matsui, Jennifer K. , Scorsetti, Marta , Clerici, Elena , Arnett, Andrea , Beyer, Sasha , Ammirati, Mario , Chakravarti, Arnab , Raval, Raju R. , Brown, Paul D. , Navarria, Pierina , Scoccianti, Silvia , Grecula, J.C., Chakravarti, Arnab , Brown, Paul D , Palmer, Joshua D , Perlow, Haley K , Chakravarti, Arnab , Scorsetti, Marta , Marrazzo, L. , Detti, Beatrice , Palmer, Joshua D.

Mayo Clinic

Cancer | March 22, 2022 | Volume: 128 | Issue: 12 | Pages: 2367-2374

10.1002/cncr.34192 | PMID 35315512 Get It

BackgroundThe standard of care for elderly or frail patients with glioblastoma (GBM) is 40 Gy in 15 fractions of radiotherapy. However, this regimen has a lower biological effective dose (BED) compared with the Stupp regimen of 60 Gy in 30 fractions. It is hypothesized that accelerated hypofractionated radiation of 52.5 Gy in 15 fractions (BED equivalent to Stupp) is safe and efficacious.MethodsElderly or frail patients with GBM treated with 52.5 Gy in 15 fractions were pooled from 3 phase 1/2 studies and a prospective observational study. Overall survival (OS) and progression‐free survival (PFS) were defined time elapsing between surgery/biopsy and death from any cause or progression of disease.ResultsSixty‐two newly diagnosed patients were eligible for this pooled analysis of individual patient data. The majority (66%) had a Karnofsky performance status (KPS) score <70. The median age was 73 years. The median OS and PFS were 10.3 and 6.9 months, respectively. Patients with KPS scores ≥70 and <70 had a median OS of 15.3 and 9.5 months, respectively. Concurrent chemotherapy was an independent prognostic factor for improved PFS and OS. Grade 3 neurologic toxicity was seen in 2 patients (3.2%). There was no grade 4/5 toxicity.ConclusionsThis is the only analysis of elderly/frail patients with GBM prospectively treated with a hypofractionated radiation regimen that is isoeffective to the Stupp regimen. Treatment was well tolerated and demonstrated excellent OS and PFS compared with historical studies. This regimen gives the elderly/frail population an alternative to regimens with a lower BED. Randomized trials are needed to validate these results.
Arthrogenic muscle inhibition manifests in thigh musculature motor unit characteristics after anterior cruciate ligament injury
Schilaty, Nathan D. , McPherson, April L. , Nagai, Takashi , Bates, Nathaniel A , Schilaty, Nathan D , Nagai, Takashi , Bates, Nathaniel A.

Mayo Clinic

European Journal of Sport Science | March 21, 2022 | Volume: 23 | Issue: 5 | Pages: 840-850

10.1080/17461391.2022.2056520 | PMID 35306977 Get It

ABSTRACTJoint trauma induces a presynaptic reflex inhibition termed arthrogenic muscle inhibition (AMI) that prevents complete activation of muscles. Reduced motor unit (MU) output is a hypothesised mechanism for persistent strength deficits. The objective of this study was to determine MU characteristics of thigh musculature and determine how they change with anterior cruciate ligament (ACL) injury compared to healthy controls. A randomised protocol of knee flexion/extension isometric contractions (10–50% maximal voluntary isometric contraction) was performed for each leg with surface EMG 5‐pin array electrodes placed on the vastus medialis, vastus lateralis, semitendinosus and biceps femoris. Longitudinal assessments for average rate coding, recruitment thresholds and MU action potentials were acquired at 6‐month intervals. With exception of the vastus medialis, all thigh musculature of ACL‐injured demonstrated smaller MU action potential peak‐to‐peak amplitude. For average rate coding, ACL‐injured demonstrated lower coding rates than Controls for the quadriceps (p < .05) and higher rates than Controls for the hamstrings (p < .05). These MU characteristics were different from Controls after ACL reconstruction up to 12 months post‐surgery, yet maximal strength increased during this time frame. As thigh MU characteristics are known across phases of ACL rehabilitation, future studies can assess these patterns of motor control and their potential to determine risk of re‐injury. Further, future rehabilitation can target specific intervention programmes to restore motor control.Highlights Motor unit strategies of arthrogenic muscle inhibition are characterised for the first time via decomposed EMG. Motor unit deficits of thigh musculature persist throughout all phases of ACL rehabilitation, even after return‐to‐sport. After ACL injury, motor unit sizes at similar recruitment thresholds were smaller than those of healthy controls.
Abstract 20985: CHA2DS2-VASc Score Predicts Risk of Incident Stroke in Patients Without Atrial Fibrillation/ Flutter in a Referral Population
Hussain, Nasir , Kopecky, Stephen L. , Allison, Thomas G. , Hussain, Nasir, Gersh, Bernard J. , Thomas, Randal J.

Mayo Clinic

Circulation | March 19, 2022 | Volume: 136 | Issue: suppl_1 | Pages: No page available

10.1161/circ.136.suppl_1.20985 Get It

Background: CHA2DS2-VASc score has been shown to predict occurrences of incident stroke in patients with history of atrial fibrillation (A-Fib)/ Flutter. However, data on whether if CHA2DS2-VASc score would predict incidence of stroke in patients without A-Fib/ Flutter is less clear. Methods: From 1993 through 2010, all patients undergoing a clinically indicated treadmill exercise test (TMET) at the Mayo Clinic, Rochester, MN were identified (N= 76,857). From this, Olmsted and neighboring counties residents were selected (N=14,095). From this, patients with age <18 years; prior history of valvular heart disease or A-Fib/ Flutter were excluded. Patient undergoing only Bruce or accelerated Naughton protocols on TMET were considered. Patients were stratified into 4 groups at baseline based on CHA2DS2-VASc score as determined at the time of TMET; group-0 score=0; group-I=1; group-2=2; group-3≥3. Patients were prospectively followed from the date of TMET until end of January 2016 for occurrence of incident stroke (ischemic and hemorrhagic). Stroke diagnosis was ascertained through retrospective chart review. Traumatic intracranial bleed was not considered. Proportional hazard regression modeling was done to assess relationship of CHA2DS2-VASc score with the stroke outcome while adjusting for METs achieved, sex, obesity, smoking status, and other relevant risk factors. Results: Final study population comprised of 12,624 patients with female comprising 37% of the cohort. Mean age in our study group was 52.2 ± 12.8 years. During an overall median follow-up of 14 (8 to 17) years, 1,255 (9.9%) patients developed incident stroke. While using CHA2DS2-VASc group-3 as referent, patients in CHA2DS2-VASc group-0 [0.18(0.14-0.23, p<.001)], group-1[0.33 (0.28-0.39, p<.001)], and group-2 [0.50 (0.43-0.58, p<.001)] were at significantly lower risk of developing stroke. Each increase of one point on the CHA2DS2-VASc scale was associated with a 51% [1.51(1.45-1.58, p<.001)] increase in incidence of stroke. Conclusion: CHA2DS2-VASc score predicts incidence of stroke in patients without history of A-Fib/ Flutter.
Hemophagocytic Lymphohistiocytosis in Refractory Celiac Disease Type II Transformed into Enteropathy-Associated T-Cell Lymphoma
Fogwe, Delvise T. , Cho, Janice , Yuan, Ji , Smyrk, Thomas C. , Ji, Yuan , Yuan, Ji , Murray, Joseph A.

Mayo Clinic

Annals of Internal Medicine: Clinical Cases | March 15, 2022 | Volume: 1 | Issue: 1 | Pages: No page available

10.7326/aimcc.2022.0155 Get It

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
Gillison, Maura L. , Maghami, Ellie, Spencer, Sharon, Pfister, David G. , Birkeland, Andrew C. , Busse, Paul M., Cmelak, Anthony J. , Eisele, David W. , Galloway, Thomas J. , Geiger, J.L. , Haddad, Robert I. , Hicks, Wesley L. , Hitchcock, Ying J. , Jimeno, Antonio , Leizman, Debra S., Mell, Loren K. , Mittal, Bharat B. , Pinto, Harlan A. , Rocco, James W. , Rodriguez, Cristina P. , Savvides, P. , Sher, David J. , Weber, Randal S. , Weinstein, Gregory S., Worden, Frank , Yom, Sue S. , Zhen, Weining, Burns, Jennifer L. , Darlow, Susan, Savvides, Panayiotis S, Haddad, Robert , Mittal, Bharat B , Yom, Sue S , Caudell, Jimmy J , Adkins, Douglas R. , Brizel, David M. , Colevas, Alexander Dimitrios , Schwartz, David A. , Shah, Jatin P. , John, Maie A. St. , Bruce, Justine Y.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 11, 2022 | Volume: 20 | Issue: 3 | Pages: 224-234

10.6004/jnccn.2022.0016 | PMID 35276673 Get It

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.
Midwest rural‐urban disparities in use of patient online services for COVID‐19
Huang, Ming , Wang, Liwei , Wang, Yanshan , Zong, Nansu , Yu, Yue , Prigge, Julie , Costello, Brian A. , Shah, Nilay D. , Ting, Henry H. , Fan, Jungwei , Prigge, Julie E, Doubeni, Chyke, Fan, Jung-Wei, Patten, Christi A. , Fan, Jungwei , Wang, Yanshan , Wen, Andrew , He, Huan , Liu, Sijia , Doubeni, Chyke A. , Liu, Hongfang

Mayo Clinic

The Journal of Rural Health | March 9, 2022 | Volume: 38 | Issue: 4 | Pages: 908-915

10.1111/jrh.12657 | PMID 35261092 Get It

AbstractPurposeRural populations are disproportionately affected by the COVID‐19 pandemic. We characterized urban‐rural disparities in patient portal messaging utilization for COVID‐19, and, of those who used the portal during its early stage in the Midwest.MethodsWe collected over 1 million portal messages generated by midwestern Mayo Clinic patients from February to August 2020. We analyzed patient‐generated messages (PGMs) on COVID‐19 by urban‐rural locality and incorporated patients’ sociodemographic factors into the analysis.FindingsThe urban‐rural ratio of portal users, message senders, and COVID‐19 message senders was 1.18, 1.31, and 1.79, indicating greater use among urban patients. The urban‐rural ratio (1.69) of PGMs on COVID‐19 was higher than that (1.43) of general PGMs. The urban‐rural ratios of messaging were 1.72‐1.85 for COVID‐19‐related care and 1.43‐1.66 for other health care issues on COVID‐19. Compared with urban patients, rural patients sent fewer messages for COVID‐19 diagnosis and treatment but more messages for other reasons related to COVID‐19‐related health care (eg, isolation and anxiety). The frequent senders of COVID‐19‐related messages among rural patients were 40+ years old, women, married, and White.ConclusionsIn this Midwest health system, rural patients were less likely to use patient online services during a pandemic and their reasons for its use differ from urban patients. Results suggest opportunities for increasing equity in rural patient engagement in patient portals (in particular, minority populations) for COVID‐19. Public health intervention strategies could target reasons why rural patients might seek health care in a pandemic, such as social isolation and anxiety.
Enrolling People of Color to Evaluate a Practice Intervention: Lessons from the Shared Decision-Making for Atrial Fibrillation (SDM4AFib) Trial
Sivly, Angela , Gorr, Haeshik, Gravholt, Derek, Hargraves, Ian , Kunneman, Marleen , Brito, Juan P. , Burnett, Bruce , Wambua, Mike , Brito, Juan P , Branda, Megan E. , Linzer, Mark , Noseworthy, Peter A. , Doubeni, Chyke A. , Suzuki, Takeki , Jackson, Elizabeth A. , Burnett, Bruce, Montori, Víctor M.

Mayo Clinic

No container title available | March 8, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1362217/v1 Get It

Abstract Background: Trial recruitment of Black, indigenous, and people of color (BIPOC) is key for interventions that interact with socioeconomic factors and cultural norms, preferences, and values. We report on our experience enrolling BIPOC participants into a multicenter trial of a shared decision-making intervention about anticoagulation to prevent strokes, in patients with atrial fibrillation (AF). Methods: We enrolled patients with AF and their clinicians in 5 healthcare systems (three academic medical centers, an urban/suburban community medical center, and a safety-net inner-city medical center) located in three states (Minnesota, Alabama, and Mississippi) in the United States. Clinical encounters were randomized to usual care with or without a shared decision-making tool about anticoagulation. Analysis: We analyzed BIPOC patient enrollment by site, categorized reasons for non-enrollment, and examined how enrollment of BIPOC patients was promoted across sites.Results: Of 2247 patients assessed, 922 were enrolled of which 147 (16%) were BIPOC patients. In comparison to trial-eligible White participants, eligible Black participants more frequently did not enroll (102 (11%) vs. 185 (15%); p <.001). The rate of BIPOC patients enrollment varied substantially by site and was generally reflective of the population served at each participating site. Enrollment of BIPOC patients benefited most from including and prioritizing practices most likely to care for BIPOC patients, with lower yield from specific efforts to reach BIPOC clinic attendees and enrolling BIPOC patients first when possible. Conclusions: Enrollment from practices that have implemented policies that favor the care of BIPOC patients can contribute to generate trustworthy estimates of the effect of these interventions in clinical practice that are applicable to BIPOC populations. Best practices to optimize the enrollment of BIPOC participants into trials that examined complex and culturally sensitive interventions remain to be developed.Clinical trial registration: ClinicalTrials.gov (NCT02905032)